-
Deletion of V483 in the spike confers evolutionary advantage on SARS-CoV-2 for human adaptation and host-range expansion after a prolonged pandemic
Yue C, Liu S, Meng B, Fan K, Yang S, Liu P, Zhu Q, Mao X, Yu Y, Shao F, Wang P, Wang Y, Gupta RK, Cao Y, Wang X. Deletion of V483 in the spike confers evolutionary advantage on SARS-CoV-2 for human adaptation and host-range expansion after a prolonged pandemic. Cell Res. 2024 Oct;34(10):739-742. doi: 10.1038/s41422-024-01000-8. Epub 2024 Jul 19. PMID: 39030295; PMCID: PMC11442493. -
Optimization and validation of a virus-like particle pseudotyped virus neutralization assay for SARS-CoV-2
Liu S, Zhang L, Fu W, Liang Z, Yu Y, Li T, Tong J, Liu F, Nie J, Lu Q, Lu S, Huang W, Wang Y. Optimization and validation of a virus-like particle pseudotyped virus neutralization assay for SARS-CoV-2. MedComm (2020). 2024 Jun 14;5(6):e615. doi: 10.1002/mco2.615. PMID: 38881676; PMCID: PMC11176738. -
HIV-1 env gene mutations outside the targeting probe affects IPDA efficiency
Zhou Z, Zhang X, Wang M, Jiang F, Tong J, Nie J, Zhao C, Zheng H, Zhang Z, Shi P, Fan W, Wang Y, Huang W. HIV-1 env gene mutations outside the targeting probe affects IPDA efficiency. iScience. 2024 May 8;27(6):109941. doi: 10.1016/j.isci.2024.109941. PMID: 38812543; PMCID: PMC11133923. -
A third dose of inactivated vaccine augments the potency, breadth, and duration of anamnestic responses against SARS-CoV-2
Jia Z, Wang K, Xie M, Wu J, Hu Y, Zhou Y, Yisimayi A, Fu W, Wang L, Liu P, Fan K, Chen R, Wang L, Li J, Wang Y, Ge X, Zhang Q, Wu J, Wang N, Wu W, Gao Y, Miao J, Jiang Y, Qin L, Zhu L, Huang W, Zhang Y, Zhang H, Li B, Gao Q, Xie XS, Wang Y, Cao Y, Wang Q, Wang X. A third dose of inactivated vaccine augments the potency, breadth, and duration of anamnestic responses against SARS-CoV-2. Protein Cell. 2024 Dec 2;15(12):930-937. doi: 10.1093/procel/pwae033. PMID: 38801319; PMCID: PMC11637481. -
COVID-19 Serum Drives Spike-Mediated SARS-CoV-2 Variation
Yu Y, Zhang M, Huang L, Chen Y, Wu X, Li T, Li Y, Wang Y, Huang W. COVID-19 Serum Drives Spike-Mediated SARS-CoV-2 Variation. Viruses. 2024 May 11;16(5):763. doi: 10.3390/v16050763. PMID: 38793644; PMCID: PMC11126028. -
A chimeric adenovirus-vectored vaccine based on Beta spike and Delta RBD confers a broad-spectrum neutralization against Omicron-included SARS-CoV-2 variants
Hong W, Lei H, Peng D, Huang Y, He C, Yang J, Zhou Y, Liu J, Pan X, Que H, Alu A, Chen L, Ai J, Qin F, Wang B, Ao D, Zeng Z, Hao Y, Zhang Y, Huang X, Ye C, Fu M, He X, Bi Z, Han X, Luo M, Hu H, Cheng W, Dong H, Lei J, Chen L, Zhou X, Wang W, Lu G, Shen G, Yang L, Yang J, Li J, Wang Z, Song X, Sun Q, Lu S, Wang Y, Cheng P, Wei X. A chimeric adenovirus-vectored vaccine based on Beta spike and Delta RBD confers a broad-spectrum neutralization against Omicron-included SARS-CoV-2 variants. MedComm (2 -
Antigenicity assessment of SARS-CoV-2 saltation variant BA.2.87.1
Yang S, Yu Y, Jian F, Yisimayi A, Song W, Liu J, Wang P, Xu Y, Wang J, Niu X, Yu L, Wang Y, Shao F, Jin R, Wang Y, Cao Y. Antigenicity assessment of SARS-CoV-2 saltation variant BA.2.87.1. Emerg Microbes Infect. 2024 Dec;13(1):2343909. doi: 10.1080/22221751.2024.2343909. Epub 2024 May 2. PMID: 38616729; PMCID: PMC11073414. -
A novel MARV glycoprotein-specific antibody with potentials of broad-spectrum neutralization to filovirus
Zhang Y, Zhang M, Wu H, Wang X, Zheng H, Feng J, Wang J, Luo L, Xiao H, Qiao C, Li X, Zheng Y, Huang W, Wang Y, Wang Y, Shi Y, Feng J, Chen G. A novel MARV glycoprotein-specific antibody with potentials of broad-spectrum neutralization to filovirus. Elife. 2024 Mar 25;12:RP91181. doi: 10.7554/eLife.91181. PMID: 38526940; PMCID: PMC10963030. -
Development of a SARS-CoV-2 neutralization assay based on a pseudotyped virus using a HIV system
Liang Z, Tong J, Wu X, Liu S, Wu J, Yu Y, Zhang L, Zhao C, Lu Q, Nie J, Huang W, Wang Y. Development of a SARS-CoV-2 neutralization assay based on a pseudotyped virus using a HIV system. MedComm (2020). 2024 Mar 22;5(4):e517. doi: 10.1002/mco2.517. PMID: 38525106; PMCID: PMC10959455. -
Characterization of a pangolin SARS-CoV-2-related virus isolate that uses the human ACE2 receptor
Xia LY, Wang XF, Cui XM, Zhang YM, Wang ZF, Li ET, Fan CF, Song K, Li YG, Ye RZ, Li FX, Zhu DY, Zhang J, Shi ZZ, Zhang MZ, Li LJ, Shen SJ, Jin S, Zhang YW, Fu WG, Zhao L, Wang WH, Wang TC, Wang YC, Jiang JF, Hu YL, Jia N, Gao YW, Cao WC. Characterization of a pangolin SARS-CoV-2-related virus isolate that uses the human ACE2 receptor. Sci China Life Sci. 2024 Jul;67(7):1502-1513. doi: 10.1007/s11427-023-2484-x. Epub 2024 Mar 8. PMID: 38478297.